Palatin Technologies Inc New (PTN) Noticias

Palatin Receives Notice of Non-Compliance from NYSE American

Palatin Receives Notice of Non-Compliance from NYSE American PR Newswire CRANBURY, N.J., Oct. 7, 2024...

Form 8-K - Current report

Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones

Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results

Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results PR Newswire CRANBURY, N.J., Sept. 26, 2024...

Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones

Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones PR...

Form 8-K - Current report

FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)

FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye...

First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity

First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities